Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 72578-103
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 72578-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viona Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mirtazapine Orally Disintegrating Tablets Usp, 15 mg (Da593f77 0b56 4eee B348 1c503d3588db 02)
Mirtazapine Orally Disintegrating Tablets Usp, 30 mg (Da593f77 0b56 4eee B348 1c503d3588db 03)
Mirtazapine Orally Disintegrating Tablets Usp, 45 mg (Da593f77 0b56 4eee B348 1c503d3588db 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.